{"id":1423,"date":"2023-09-28T09:17:36","date_gmt":"2023-09-28T00:17:36","guid":{"rendered":"https:\/\/c-mng.cwh.hokudai.ac.jp\/gcb.med\/JP\/?page_id=1423"},"modified":"2023-10-25T20:36:26","modified_gmt":"2023-10-25T11:36:26","slug":"verbal_presentations2022","status":"publish","type":"page","link":"https:\/\/c-mng.cwh.hokudai.ac.jp\/gcb.med\/JP\/verbal_presentations2022.html","title":{"rendered":"\u5b66\u4f1a\u767a\u8868\u3000April 2022 \u2013 March 2023"},"content":{"rendered":"

Keynote Speeches\uff1a\u57fa\u8abf\u8b1b\u6f14(\u56fd\u5185)<\/h3>
  1. \u300c\u533b\u7642\u306b\u304a\u3051\u308b\u793e\u4f1a\u60c5\u5831\u57fa\u76e4\u3068AI\u300d.\u3000\u4e2d\u8c37 \u7d14\uff0e\u5317\u6d77\u9053\u5927\u5b66\u5927\u5b66\u9662\u533b\u5b66\u7814\u7a76\u9662\u30fb\u533b\u5b66\u9662\u30fb\u533b\u5b66\u90e8\u533b\u5b66\u79d1. \u300c\u65b0\u4efb\u6559\u6388\u7279\u5225\u30bb\u30df\u30ca\u30fc\u300d.\u30002022\u5e7412\u670822\u65e5<\/li>
  2. \u300cICD-11\u3068AI\u300d\u3000\u4e2d\u8c37\u3000\u7d14\u3000\u3000\u7b2c47\u56de\u65e5\u672c\u8a3a\u7642\u60c5\u5831\u7ba1\u7406\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a2021\u5e7410\u67087\u65e5\uff5e11\u67086\u65e5\u30aa\u30f3\u30c7\u30de\u30f3\u30c9\u914d\u4fe1\u3000\uff080248\u3000\u8a3a\u7642\u60c5\u5831\u7ba1\u740634-1 2022.04.19\u3000\u518d\u6821\uff09<\/li>
  3. WHO-FIC\u3092\u77e5\u308d\u3046\uff1aWHO-FIC\u306e\u6d3b\u52d5\u3068ICD-11\uff08ITC\u306e\u89b3\u70b9\u304b\u3089\uff09\uff0e\u3000\u4e2d\u8c37\u3000\u7d14\uff0eThe 48th Annual Meeting of Japan Society of Health Information Management
    \u7b2c48\u56de\u3000\u65e5\u672c\u8a3a\u7642\u60c5\u5831\u7ba1\u7406\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\uff0e2022\u5e749\u6708\uff0e<\/li><\/ol>

    Invited Lectures [Japanese Conference]\uff1a\u62db\u5f85\u8b1b\u6f14(\u56fd\u5185)<\/h3>
    1. \u9ad8\u5c3e\u8056\u5fc3\uff1a\u7b2c36\u56de\u9ad8\u7cbe\u5ea6\u653e\u5c04\u7dda\u5916\u90e8\u7167\u5c04\u90e8\u4f1a
      \u6f14\u984c\u540d\uff1aResearch topics on daily and real-time adaptive proton therapy in Hokkaido University\u30002023\u5e743\u67083\u65e5\u3000\u67cf\u306e\u8449\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u30bb\u30f3\u30bf\u30fc\uff08\u5343\u8449\u770c\u67cf\u5e02\uff09<\/li>
    2. Yoshimura T: AI\u3092\u7528\u3044\u305f\u533b\u7528\u753b\u50cf\u306e\u753b\u8cea\u6539\u5584\u304a\u3088\u3073\u753b\u50cf\u751f\u6210\u306b\u95a2\u3059\u308b\u53d6\u308a\u7d44\u307f. \u7b2c\uff11\u56de\u5317\u5927\u533b\u7642AI\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, Sapporo, 2022.11.<\/li>
    3. \u5c0f\u91ce\u5bfa\u5eb7\u4ec1\uff1a\u816b\u760d\u5fae\u5c0f\u74b0\u5883\u306e\u4ee3\u8b1d\u5236\u5fa1\u3068\u653e\u5c04\u7dda\u6cbb\u7642
      \u7b2c59\u56de\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u751f\u7269\u90e8\u4f1a\u5b66\u8853\u5927\u4f1a\u30fb\u7b2c50\u56de\u653e\u5c04\u7dda\u306b\u3088\u308b\u5236\u764c\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff082022\u5e746\u670825\u65e5\u3001\u672d\u5e4c\uff09<\/li>
    4. \u767d\u571f\u535a\u6a39\uff1a2\u339c\u306e\u91d1\u30de\u30fc\u30ab\u30fc\u304b\u3089\u59cb\u307e\u3063\u305f\u6311\u6226
      \u3010\u4ee4\u548c4\u5e74\u5ea6\u516c\u76ca\u8ca1\u56e3\u6cd5\u4eba\u4f0a\u85e4\u533b\u85ac\u5b66\u8853\u4ea4\u6d41\u8ca1\u56e3\u8d08\u5448\u5f0f\u3011\u4f0a\u85e4\u592a\u90ce\u5b66\u8853\u8cde\u53d7\u8cde\u8a18\u5ff5\u8b1b\u6f14\uff082022\/9\/7\u3001\u672d\u5e4c\uff09<\/li>
    5. \u767d\u571f\u535a\u6a39\uff1a\u304c\u3093\u306e\u653e\u5c04\u7dda\u6cbb\u7642\u3000\u30fc\u5317\u5927\u304b\u3089\u4e16\u754c\u3078\u30fc
      \u3010\u30d5\u30e9\u30c6\u796d2022\u3011\u7279\u5225\u8b1b\u6f14\uff082022\/9\/24\u3001WEB\uff09<\/li>
    6. \u767d\u571f\u535a\u6a39\uff1a\u79d1\u5b66\u306e\u7c8b\u3092\u96c6\u3081\u305f\u6700\u5148\u7aef\u533b\u7642\uff1a\u653e\u5c04\u7dda\u6cbb\u7642\u3068\u3068\u3082\u306b
      \u3010\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c35\u56de\u5b66\u8853\u5927\u4f1a\u3011Gold Medal \u53d7\u8cde\u8a18\u5ff5\u8b1b\u6f14\uff082022\/10\/10-12\u3001\u5e83\u5cf6\uff09<\/li>
    7. \u767d\u571f\u535a\u6a39\uff1a\u9ad8\u7cbe\u5ea6\u653e\u5c04\u7dda\u5916\u90e8\u7167\u5c04\u306e\u6587\u5316\u3068\u672c\u5f53\u306e\u8ab2\u984c
      \u3010\u7b2c36\u56de\u9ad8\u7cbe\u5ea6\u653e\u5c04\u7dda\u5916\u90e8\u7167\u5c04\u90e8\u4f1a\u5b66\u8853\u5927\u4f1a\uff0f\u7b2c7\u56de\u9ad9\u6a4b\u4fe1\u6b21\u8a18\u5ff5\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3011\u7279\u5225\u8b1b\u6f14\uff082023\/3\/3-4\u3001\u5343\u8449\u770c\u67cf\u5e02\uff09<\/li>
    8. \u767d\u571f\u535a\u6a39\uff1a\u52b9\u679c\u3068\u4fa1\u5024\u306b\u3064\u3044\u3066
      \u3010\u7b2c36\u56de\u9ad8\u7cbe\u5ea6\u653e\u5c04\u7dda\u5916\u90e8\u7167\u5c04\u90e8\u4f1a\u5b66\u8853\u5927\u4f1a\uff0f\u7b2c7\u56de\u9ad9\u6a4b\u4fe1\u6b21\u8a18\u5ff5\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3011\u30b7\u30f3\u30dd\u30b8\u30a6\u30e04\u300c\u9ad8\u7cbe\u5ea6\u653e\u5c04\u7dda\u6cbb\u7642\u306e\u8cbb\u7528\u5bfe\u52b9\u679c\uff08\u7c92\u5b50\u7dda\u6cbb\u7642\u3082\u542b\u3080\uff09\u300d\u6307\u5b9a\u767a\u8a00\uff082023\/3\/3-4\u3001\u5343\u8449\u770c\u67cf\u5e02\uff09<\/li>
    9. \u7b2c81\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\u3001\u6a2a\u6d5c\u5e02\u30012022.4.16
      \u5de5\u85e4\u8207\u4eae\uff1aMRI\u306b\u3088\u308b\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u306e\u65e9\u671f\u767a\u898b<\/li>
    10. \u00a0ASMRM, Web, 2022.5.21
      Kudo K: Perfusion-Diffusion Mismatch in Acute Ischemic Stroke<\/li>
    11. \u5e2f\u5e83\u795e\u7d4c\u753b\u50cf\u691c\u8a0e\u4f1a\u3001\u5e2f\u5e83\u5e02\u30012022.5.27\u3001
      \u5de5\u85e4\u8207\u4eae\uff1a\u4e2d\u67a2\u795e\u7d4c\u7cfb\u539f\u767a\u60aa\u6027\u30ea\u30f3\u30d1\u816b\uff08PCNSL\uff09\u306e\u753b\u50cf\u8a3a\u65ad<\/li>
    12. \u7b2c23\u56deMR\u5165\u9580\u8b1b\u5ea7\u3001Web\u958b\u50ac\u30012022.6.11
      \u5de5\u85e4\u8207\u4eae\uff1aMR\u691c\u67fb\u306e\u57fa\u790e\uff1a\u4e2d\u67a2\u795e\u7d4c\u30fb\u810a\u690e\u9818\u57df<\/li>
    13. \u7b2c31\u56de\u65e5\u672c\u8133\u30c9\u30c3\u30af\u5b66\u4f1a\u7dcf\u4f1a\u3001\u795e\u5948\u5ddd\u770c\u5927\u78ef\u753a\u30012022.6.23
      \u5de5\u85e4\u8207\u4eae\uff1aQSM\u3068\u6c34\u52d5\u614bMRI\u306b\u3088\u308b\u8a8d\u77e5\u75c7\u8a3a\u65ad<\/li>
    14. \u753b\u50cf\u8a3a\u65adWEB\u30d5\u30a9\u30fc\u30e9\u30e0\u3001Web\u958b\u50ac\u30012022.7.28
      \u5de5\u85e4\u8207\u4eae\uff1a\u653e\u5c04\u7dda\u8a3a\u65ad\u3068\u533b\u7642AI<\/li>
    15. 5th GCB Biomedical Science and Engineering Summer School, Web,\u30002022.8.22
      Kudo K: Overview of Medical AI<\/li>
    16. \u624b\u7a32\u6e13\u4ec1\u4f1a\u75c5\u9662\u30a8\u30ad\u30b9\u30d1\u30fc\u30c8\u30ec\u30af\u30c1\u30e3\u30fc\u3001\u672d\u5e4c\u5e02\u30012022.9.6
      \u5de5\u85e4\u8207\u4eae\uff1a\u8133\u5352\u4e2d\u306e\u753b\u50cf\u8a3a\u65ad<\/li>
    17. \u7b2c50\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a\u3001\u540d\u53e4\u5c4b\u5e02\uff08\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9\u958b\u50ac\uff09\u30012022.9.9
      \u5de5\u85e4\u8207\u4eae\uff1aAI\u652f\u63f4\u306b\u3088\u308bMRI\u5b9a\u91cf\u89e3\u6790<\/li>
    18. \u5de5\u85e4\u8207\u4eae\uff1aO-17\u6a19\u8b58\u6c34\uff08PSO17\uff09\u3092\u7528\u3044\u305f\u6c34\u52d5\u614b\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0<\/li>
    19. AOCR 2022, Seoul, Korea, 2022.9.20
      Kudo K: QSM in Neuroimaging<\/li>
    20. \u7b2c5\u56de\u82eb\u5c0f\u7267\u753b\u50cf\u7814\u7a76\u4f1a\u3001\u5c0f\u6a3d\u5e02\u30012022.10.6
      \u5de5\u85e4\u8207\u4eae\uff1a\u5b9a\u91cf\u7684\u78c1\u5316\u7387\u30de\u30c3\u30d4\u30f3\u30b0\uff08QSM\uff09\u306e\u81e8\u5e8a\u5fdc\u7528\uff1a\u8133\u304b\u3089\u5168\u8eab\u3078<\/li>
    21. \u7b2c65\u56de\u65e5\u672c\u8133\u5faa\u74b0\u4ee3\u8b1d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u3001\u7532\u5e9c\u5e02\uff08\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9\u958b\u50ac\uff09\u30012022.10.28
      \u5de5\u85e4\u8207\u4eae\uff1aMRI\u306b\u3088\u308bOEF\u30de\u30c3\u30d4\u30f3\u30b0\u306e\u958b\u767a\u3068\u5c55\u671b<\/li>
    22. \u540d\u53e4\u5c4b\u5148\u7aef\u91cf\u5b50\u533b\u5b66\u30d5\u30a9\u30fc\u30e9\u30e0\u3001\u540d\u53e4\u5c4b\u5e02\u30012022.10.28
      \u5de5\u85e4\u8207\u4eae\uff1a17O-MRI\u306e\u958b\u767a\u3068\u5c06\u6765\u5c55\u671b<\/li>
    23. \u7b2c40\u56de\u65e5\u672c\u795e\u7d4c\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u3001\u798f\u5cf6\u770c\u90e1\u5c71\u5e02\u30012022.11.4
      \u5de5\u85e4\u8207\u4eae\uff1a\u795e\u7d4c\u5909\u6027\u75be\u60a3\u306b\u304a\u3051\u308b\u5b9a\u91cf\u7684\u78c1\u5316\u7387\u30de\u30c3\u30d4\u30f3\u30b0\uff08QSM\uff09\u306e\u81e8\u5e8a\u5fdc\u7528<\/li>
    24. \u5e2f\u5e83\u795e\u7d4c\u753b\u50cf\u691c\u8a0e\u4f1a\u3001\u5e2f\u5e83\u5e02\u30012022.11.25
      \u5de5\u85e4\u8207\u4eae\uff1a\u30d1\u30fc\u30ad\u30f3\u30bd\u30f3\u75c7\u72b6\u3068\u753b\u50cf\u8a3a\u65ad<\/li>
    25. \u7b2c96\u56de\u65e5\u672c\u85ac\u7406\u5b66\u4f1a\u5e74\u4f1a\u3001\u6a2a\u6d5c\u5e02\u30012022.11.30
      \u5de5\u85e4\u8207\u4eae\uff1aMRI\u3092\u7528\u3044\u305f\u8133\u5185\u6c34\u52d5\u614b\u306e\u30de\u30af\u30ed\u30ec\u30d9\u30eb\u3067\u306e\u53ef\u8996\u5316<\/li>
    26. \u7b2c9\u56de\u5bcc\u5c71\u8133\u6a5f\u80fd\u753b\u50cf\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u3001\u5bcc\u5c71\u5e02\u30012023.3.3
      \u5de5\u85e4\u8207\u4eae\uff1aMRI\u78c1\u5316\u7387\u3092\u5229\u7528\u3057\u305fOEF\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0<\/li>
    27. \u4e80\u7530\u6d69\u4e4b\u300117O-MRI\u306e\u4e2d\u67a2\u795e\u7d4c\u9818\u57df\u306b\u304a\u3051\u308b\u5c55\u958b\u3001\u7b2c50\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a\u30012022\u5e749\u67089\u65e5-11\u65e5\u3001\u540d\u53e4\u5c4b<\/li>
    28. \u7279\u5225\u4f01\u753b\uff1a\u300cWHO-FIC\u306e\u6d3b\u52d5\u3068ICD-11\u300d\uff0e\u3000\u4e2d\u8c37\u3000\u7d14\uff0e\u3000\u7b2c48\u56de\u65e5\u672c\u8a3a\u7642\u60c5\u5831\u7ba1\u7406\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\uff0e\u30002022 \u5e74 9 \u6708\uff0e\u3000\u9ad8\u77e5\u770c\u7acb\u770c\u6c11\u6587\u5316\u30db\u30fc\u30eb\u304a\u3088\u3073\u9ad8\u77e5\u4f1a\u9928
      \u5927\u4f1a\u30c6\u30fc\u30de\uff1a\u300c\u4eca\u3001\u6c42\u3081\u3089\u308c\u308b\u8a3a\u7642\u60c5\u5831\u7ba1\u7406\u306e\u4e0d\u6613\u6d41\u884c\u300d\uff0e\u3000<\/li><\/ol>

      Invited Lectures [International Conference]\uff1a\u62db\u5f85\u8b1b\u6f14(\u56fd\u969b)<\/h3>
      1. Hidefumi Aoyama: Session3 The Management of Brain Metastasis in The Era of Oligometastases. 2022 Carbon Ion Therapy Symposium, Seoul Radiation Oncology Symposium 2022.4 Seoul<\/li>
      2. Yasuhito Onodera : Metabolic manipulation for cancer research and therapy MJB Symposium\uff082022\u5e745\u670812\u65e5\u3001New York\uff09<\/li>
      3. Yasuhito Onodera: Regulated spatial distribution of mitochondria reconciles invasiveness and redox homeostasis of cancer cells<\/li>
      4. \u3010The 12th International NO Conference & The 22nd NOSJ\u3000\u3011Session N13 NO and supersulfides in Signal Transduction\uff082022\u5e7410\u670830\u65e5\u3001\u4ed9\u53f0\uff09<\/li>
      5. Shirato H \uff1a1st Proton Therapy Research Workshop - New Horizons in Proton Therapy Planning - April 21-22, 2022, Mayo Clinic, Arizona USA (via web)<\/li>
      6. The 8th Jishuitan Orthopedics Forum (JOF), 2022.4.16-17
        Beijing Jishuitan Hospital Cartilage evaluation of RA
        Tamotsu Kamishima<\/li>
      7. 24th Annual Conference of Asian Musculoskeletal Society,Web\u958b\u50ac,2022.9.17-9.18 2022.9.24-25
        Imaging of congenital spinal disease
        Tamotsu Kamishima<\/li>
      8. Tha KK. \"Noninvasive Assessment of Tissue Electrical Conductivity: Potential Clinical Value\". ICBEM-ICEBI-EIT 2022.<\/li>
      9. Tha KK. \"Electrical Conductivity in Normal and Pathological Tissues\". The 2022 joint workshop on MR phase, magnetic susceptibility and electrical properties mapping.<\/li>
      10. Tha KK. \"Noninvasive assessment of tumor: the role of radiomics and radiogenomics\". The 5th GCB Summer School for Biomedical Science and Engineering.<\/li>
      11. Tha KK. \"How AI can shape diagnostic imaging practice\". The 29th Chinese Congress of Radiology.<\/li><\/ol>

        Other Presentations [Japanese Conference]\uff1a\u5b66\u4f1a\u767a\u8868(\u56fd\u5185)<\/h3>
        1. \u6728\u4e0b\u7559\u7f8e\u5b50\u3001\u6253\u6d6a\u96c4\u4ecb\u3001\u5c0f\u6cc9\u5bcc\u57fa\u3001\u897f\u5ca1\u5065\u592a\u90ce\u3001\u6a4b\u672c\u5b5d\u4e4b\u3001\u52a0\u85e4\u6276\u7f8e\u3001\u4e09\u7530\u6751\u5353\u3001\u4f0a\u85e4\u967d\u4e00\u3001\u677e\u91ce\u5409\u5b8f\u3001\u9752\u5c71\u82f1\u53f2\uff1aTreatment Outcome of Definitive\u3000Radiotherapy\u3000for\u3000Cervical\u3000Cancer\uff0e\u3000\u7b2c81\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\u30002022.4.14-17\u3000\u6a2a\u6d5c<\/li>
        2. \u68ee \u5d07\u3001\u5c71\u53e3\u3000\u79c0\u3001\u8302\u6728\u6d0b\u6643\u3001\u897f\u5ca1\u5065\u592a\u90ce\u3001\u5c0f\u6cc9\u5bcc\u57fa\u3001\u85e4\u7530\u7965\u535a\u3001 \u9752\u5c71\u82f1\u53f2\uff1a\u5f53\u9662\u306e\u8ee2\u79fb\u6027\u8133\u816b\u760d\u8853\u5f8c\u5b9a\u4f4d\u7167\u5c04\u75c7\u4f8b\u306e\u691c\u8a0e. \u7b2c31\u56de\u65e5\u672c\u5b9a\u4f4d\u653e\u5c04\u7dda\u6cbb\u7642\u5b66\u4f1a\u30002022.5.26-27 \u6771\u4eac\/Web<\/li>
        3. \u6728\u4e0b\u7559\u7f8e\u5b50\u3001\u6a9c\u57a3\u6714\u3001\u85e4\u7530\u7965\u535a\u3001\u68ee\u5d07\u3001\u897f\u5ca1\u5065\u592a\u90ce\u3001\u62bc\u91ce\u667a\u535a\u3001\u52a0\u85e4\u6276\u7f8e\u3001\u91d1\u5e73\u5b5d\u535a\u3001\u6a4b\u672c\u5b5d\u4e4b\u3001\u9ad8\u6a4b\u5c07\u4eba\u3001\u9752\u5c71\u82f1\u53f2\uff1a\u5f37\u5ea6\u5909\u8abf\u56de\u8ee2\u7167\u5c04\u6cd5\uff08\uff36\uff2d\uff21\uff34\uff09\u3067\u8853\u5f8c\u7167\u5c04\u3092\u884c\u3063\u305f2\u4f8b\u3000\u7b2c20\u56de\u65e5\u672c\u4e73\u764c\u5b66\u4f1a\u5317\u6d77\u9053\u5730\u65b9\u4f1a\u30002022.9\u30fb10\u3000\u672d\u5e4c<\/li>
        4. \u9ad8\u6a4b\u5468\u5e73\u3001\u897f\u5ca1\u5065\u592a\u90ce\u3001\u68ee\u3000\u5d07\u3001\u5c71\u53e3\u3000\u79c0\u3001\u9752\u5c71\u82f1\u53f2\uff1a\u5f53\u9662\u306b\u304a\u3051\u308b\u81a0\u82bd\u816b\u3078\u306e\u8853\u5f8c\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\u306e\u6cbb\u7642\u6210\u7e3e\u304a\u3088\u3073\u518d\u767a\u69d8\u5f0f\u306b\u95a2\u3059\u308b\u7814\u7a76.\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c35\u56de\u5b66\u8853\u5927\u4f1a\u30002022.11.10-12 \u5e83\u5cf6<\/li>
        5. \u85e4\u7530\u7965\u535a\u3001\u52a0\u85e4\u5fb3\u96c4\u3001\u6253\u6d6a\u96c4\u4ecb\u3001\u963f\u4fdd\u5927\u4ecb\u3001\u7530\u53e3\u5927\u5fd7\u3001\u897f\u5ca1\u5065\u592a\u90ce\u3001\u5b89\u7530\u8015\u4e00\u3001\u5c0f\u6cc9\u5bcc\u57fa\u3001\u5fd7\u85e4\u5143\u6cf0\u3001\u897f\u5ddd\u3000\u6607\u3001\u5bae\u672c\u76f4\u6a39\u3001\u9ad8\u5c3e\u8056\u5fc3\u3001\u5c0f\u5ddd\u6d69\u53f8\u3001\u67ff\u5742\u9054\u5f66\u3001\u6a4b\u672c\u5b5d\u4e4b\u3001\u9752\u5c71\u82f1\u53f2\uff1a\u809d\u5185\u80c6\u7ba1\u764c\u306b\u5bfe\u3059\u308b\u80f4\u4f53\u8ffd\u8de1\u7167\u5c04\u30b7\u30b9\u30c6\u30e0\u3092\u7528\u3044\u305fX\u7dda\u6cbb\u7642\u3088\u3073\u967d\u5b50\u7dda\u6cbb\u7642\u6210\u7e3e\u306e\u691c\u8a0e. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c35\u56de\u5b66\u8853\u5927\u4f1a\u30002022.11.10-12 \u5e83\u5cf6<\/li>
        6. \u6728\u4e0b\u7559\u7f8e\u5b50\u3001\u897f\u5ca1\u5065\u592a\u90ce\u3001\u68ee\u3000\u5d07\u3001\u6a9c\u57a3\u3000\u6714\u3001\u9ad9\u6a4b\u5468\u5e73\u3001\u85e4\u7530\u7965\u535a\u3001\u6a4b\u672c\u5b5d\u4e4b\u3001\u9752\u5c71\u82f1\u53f2\uff1a\u5317\u6d77\u9053\u5927\u5b66\u75c5\u9662\u306b\u304a\u3051\u308b\u5b50\u5bae\u9838\u764c\u306b\u5bfe\u3059\u308b\u8154\u5185\u7167\u5c04\u65bd\u884c\u75c7\u4f8b\u306e\u53d7\u7642\u52d5\u5411\u306b\u3064\u3044\u3066\u306e\u8abf\u67fb.\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c35\u56de\u5b66\u8853\u5927\u4f1a\u30002022.11.10-12 \u5e83\u5cf6<\/li>
        7. \u5c0f\u6cc9\u5bcc\u57fa\u3001\u52a0\u85e4\u5fb3\u96c4\u3001\u5ddd\u672c\u6cf0\u4e4b\u3001\u4e2d\u6751\u3000\u900f\u3001\u67ff\u5742\u9054\u5f66\u3001\u7530\u53e3\u5927\u5fd7\u3001\u6253\u6d6a\u96c4\u4ecb\u3001\u897f\u5ddd\u3000\u6607\u3001
          \u5fd7\u85e4\u5143\u6cf0\u3001\u85e4\u7530\u7965\u535a\u3001\u6728\u4e0b\u7559\u7f8e\u5b50\u3001\u5b89\u7530\u8015\u4e00\u3001\u897f\u5ca1\u5065\u592a\u90ce\u3001\u68ee\u3000\u5d07\u3001\u6a4b\u672c\u5b5d\u4e4b\u3001\u9752\u5c71\u82f1\u53f2\uff1a\u81b5\u764c\u306b\u5bfe\u3059\u308b\u540c\u6642\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\u306e\u9061\u53ca\u7684\u89e3\u6790.\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c35\u56de\u5b66\u8853\u5927\u4f1a\u30002022.11.10-12 \u5e83\u5cf6<\/li>
        8. \u6253\u6d6a\u96c4\u4ecb\u3001\u52a0\u85e4\u5fb3\u96c4\u3001\u85e4\u7530\u7965\u535a\u3001\u7530\u53e3\u5927\u5fd7\u3001\u9234\u6728\u9686\u4ecb\u3001\u91d1\u5e73\u5b5d\u535a\u3001\u9ad8\u5c3e\u8056\u5fc3\u3001\u5c0f\u6a4b\u5553\u53f8\u3001
          \u9752\u5c71\u82f1\u53f2\uff1a\u30c1\u30e3\u30a4\u30eb\u30c9\u5206\u985eB\u30015cm\u4ee5\u4e0b\u306e\u809d\u304c\u3093\u306b\u304a\u3051\u308b\u30e2\u30c7\u30eb\u30d9\u30fc\u30b9\u30bb\u30ec\u30af\u30b7\u30e7\u30f3\u306b\u5411\u3051\u305f\u691c\u8a0e. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c35\u56de\u5b66\u8853\u5927\u4f1a\u30002022.11.10-12 \u5e83\u5cf6<\/li>
        9. \u9ad8\u6a4b \u5468\u5e73\u3001\u68ee \u5d07\u3001\u6253\u6d6a \u96c4\u4ecb\u3001\u897f\u5ca1 \u5065\u592a\u90ce\u3001\u8302\u6728 \u6d0b\u6643\u3001\u5c71\u53e3 \u79c0\u3001\u9752\u5c71 \u82f1\u53f2\uff1a\u5f53\u9662\u306b\u304a\u3051\u308b\u8ee2\u79fb\u6027\u8133\u816b\u760d\u3078\u306e\u8853\u5f8c\u5b9a\u4f4d\u7167\u5c04\u75c7\u4f8b\u306e\u691c\u8a0e. \u7b2c36\u56de\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u9ad8\u7cbe\u5ea6\u653e\u5c04\u7dda\u5916\u90e8\u7167\u5c04\u90e8\u4f1a\u5b66\u8853\u5927\u4f1a\u30002023.3.3-4 \u5343\u8449<\/li>
        10. \u5b89\u7530\u8015\u4e00\u3001\u6253\u6d6a\u96c4\u4ecb\u3001\u6d5c\u7530\u8aa0\u4e8c\u90ce\u3001\u9234\u6728\u5d07\u7965\u3001\u5bfe\u99ac\u90a3\u7531\u591a\u3001\u7530\u53e3\u7d14\u3001\u6e05\u6c34\u5eb7\u3001\u52a0\u7d0d\u91cc\u5fd7\u3001\u672c\u9593\u660e\u5b8f\uff1a\u9ad8\u9f62\u306e\u982d\u9838\u90e8\u60aa\u6027\u816b\u760d\u306b\u5bfe\u3059\u308b\u653e\u5c04\u7dda\u6cbb\u7642\u306e\u5f8c\u308d\u5411\u304d\u691c\u8a0e. \u7b2c46\u56de\u65e5\u672c\u982d\u9838\u90e8\u764c\u5b66\u4f1a\u30002022.6.17-18 \u5948\u826f<\/li>
        11. \u5b89\u7530\u8015\u4e00\u3001\u6253\u6d6a\u96c4\u4ecb, \u5bae\ufa11\u667a\u5f66, \u85e4\u7530\u7965\u535a, \u897f\u5ddd\u6607, \u5fd7\u85e4\u5143), \u9ad8\u6a4b\u5468), \u7530\u53e3\u7d14, \u9234\u6728\u5d07\u7965, \u5bfe\u99ac\u90a3\u7531\u591a, \u52a0\u7d0d\u91cc), \u51fa\u5009\u5eb7\u88d5, \u5927\u585a\u611b\u7f8e, \u6e4a\u5ddd\u82f1\u6a39, \u9577\u8c37\u5ddd\u96c5\u4e00, \u571f\u5c4b\u548c\u5f66, \u9b3c\u4e38\u529b\u4e5f, \u6e05\u6c34\u5eb7, \u672c\u9593\u660e\u5b8f, \u9752\u5c71\u82f1\u53f2\uff1a\u5317\u6d77\u9053\u5927\u5b66\u75c5\u9662\u306b\u304a\u3051\u308b\u4e0a\u54bd\u982d\u764c\u6cbb\u7642 - 10\u5e74\u9593\uff082011-2020\u5e74\uff09\u306e\u307e\u3068\u3081 - \u7b2c26\u56de\u5317\u65e5\u672c\u982d\u9838\u90e8\u764c\u6cbb\u7642\u7814\u7a76\u4f1a. 2022.10.1 \u4ed9\u53f0<\/li>
        12. \u77f3\u5ddd\u6b63\u7d14\u3001\u300c\u9ad8\u7cbe\u5ea6\u5149\u514d\u75ab\u6cbb\u7642\u30b7\u30b9\u30c6\u30e0\u306e\u958b\u767a \uff5e\u5317\u6d77\u9053\u5927\u5b66\u306b\u304a\u3051\u308b\u53d6\u308a\u7d44\u307f\u306e\u3054\u7d39\u4ecb\uff5e\u300d\u7b2c123\u56de\u65e5\u672c\u533b\u5b66\u7269\u7406\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\uff082022.4.14-17\uff09\u6a2a\u6d5c<\/li>
        13. \u77f3\u5ddd\u6b63\u7d14\u3001\u6cc9\u99c6\u3001\u66fd\u5c71\u6b66\u58eb\u3001\u9234\u6728\u5d07\u7965\u3001\u8db3\u5229\u96c4\u4e00\u3001\u6a0b\u7530\u6cf0\u6d69\u3001\u300c\u5149\u514d\u75ab\u7642\u6cd5\u5c02\u7528\u6cbb\u7642\u8a08\u753b\u88c5\u7f6e\u306e\u958b\u767a\u300d\u7b2c124\u56de\u65e5\u672c\u533b\u5b66\u7269\u7406\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\uff082022.9.16-17\uff09\u9577\u5d0e<\/li>
        14. \u6cc9\u99c6\u3001\u77f3\u5ddd\u6b63\u7d14\u3001\u66fd\u5c71\u6b66\u58eb\u3001\u9234\u6728\u5d07\u7965\u3001\u8db3\u5229\u96c4\u4e00\u3001\u6a0b\u7530\u6cf0\u6d69\u3001\u300c\u5149\u514d\u75ab\u7642\u6cd5\u6cbb\u7642\u8a08\u753b\u88c5\u7f6e\u306e\u305f\u3081\u306e\u5149\u5b66\u8f38\u9001\u8a08\u7b97\u30b3\u30fc\u30c9\u306e\u958b\u767a\u300d\u7b2c124\u56de\u65e5\u672c\u533b\u5b66\u7269\u7406\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\uff082022.9.16-17\uff09\u9577\u5d0e<\/li>
        15. \u77f3\u5ddd\u6b63\u7d14\u3001\u98ef\u7530\u5149\u3001\u5343\u8449\u8c6a\u300c\u6c7a\u5b9a\u8ad6\u7684\u7c92\u5b50\u8f38\u9001\u8a08\u7b97\u30b3\u30fc\u30c9 CBZ \u3092\u7528\u3044\u305f BNCT \u5c02\u7528\u52a0\u901f\u5668\u4e2d\u6027\u5b50\u7167\u5c04\u8a2d\u5099\u306e Beam Shaping Assembly \u6700\u9069\u5316\u300d\u7b2c18\u56de\u65e5\u672c\u4e2d\u6027\u5b50\u6355\u6349\u7642\u6cd5\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\uff082022.10.29-30\uff09\u3064\u304f\u3070<\/li>
        16. M. Ishikawa, K. Baba, R. Ogawara, T. Kusumoto, T. Hamano, \u201cFeasibility study on quenching effect correction in organic scintillator for high-LET particles,\u201d 2022 IEEE Nuclear Science Symposium and Medical Imaging Conference (2022.11.5-11.12) Milano<\/li>
        17. \u77f3\u5ddd \u6b63\u7d14\u3001\u5cef\u6751\u4fca\u884c\u3001\u9060\u5c71 \u5c1a\u7d00\u3001\u5c0f\u91ce \u667a\u535a\u3001\u9ad8\u6a4b \u826f\u3001\u5ca1\u672c\u88d5\u4e4b\u3001\u897f\u5c3e \u798e\u6cbb\u3001\u6238\u677f\u5b5d\u6587\u300cBland-Altman\u89e3\u6790\u3092\u7528\u3044\u305f\u60a3\u8005\u500b\u5225QA\u7dda\u91cf\u5206\u5e03\u89e3\u6790\u6cd5\u306e\u691c\u8a0e\u300d\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c35\u56de\u5b66\u8853\u5927\u4f1a(2022.11.10-12) \u5e83\u5cf6<\/li>
        18. \u5c0f\u5cf6 \u79c0\u6a39\u3001\u77f3\u5ddd \u6b63\u7d14\u3001\u300c\u30de\u30a4\u30af\u30ed\u578b\u96fb\u96e2\u7bb1\u306b\u304a\u3051\u308b\u967d\u30a4\u30aa\u30f3\u53ce\u96c6\u3092\u7528\u3044\u305f\u7dda\u91cf\u6e2c\u5b9a\u7cbe\u5ea6\u5411\u4e0a\u306b\u95a2\u3059\u308b\u691c\u8a0e\u300d\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c35\u56de\u5b66\u8853\u5927\u4f1a(2022.11.10-12) \u5e83\u5cf6<\/li>
        19. \u77f3\u5ddd\u6b63\u7d14\u3001\u67f4\u7530\u96bc\u300c\u591a\u70b9\u8a08\u6e2c\u53ef\u80fd\u306a\u76ae\u819a\u88ab\u3070\u304f\u7dda\u91cf\u306e\u958b\u767a\uff5e\u591a\u30c1\u30e3\u30f3\u30cd\u30eb\u578bMIDSOF\u306e\u4f7f\u7528\u4f8b\u5831\u544a\uff5e\u300d2022\u5e74\u5ea6\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u5317\u6d77\u9053\u652f\u90e8\u79cb\u5b63\u5927\u4f1a \u8a08\u6e2c\u9632\u8b77\u30bb\u30df\u30ca\u30fc(2022.11.13) \u672d\u5e4c<\/li>
        20. \u7b2c124\u56de\u65e5\u672c\u533b\u5b66\u7269\u7406\u5b66\u4f1a\uff0cPerformance evaluation of real-time volumetric imaging based on CT image deformation in abdominal region\uff0cSaiko Kon, Seishin Takao, Yuhei Kikkawa, Kohei Yokokawa, Taeko Matsuura, Hiroshi Taguchi, Yusuke Uchinami, Norio Katoh, Hidefumi Aoyama, and Naoki Miyamoto.<\/li>
        21. \u7b2c124\u56de\u65e5\u672c\u533b\u5b66\u7269\u7406\u5b66\u4f1a\uff0cPerformance evaluation of volumetric imaging based on motion modeling with multiple 4DCT datasets\uff0cKeishi Oseki, Kikuo Umegaki, Taeko Matsuura, Seishin Takao, Kohei Yokokawa, Koichi Miyazaki, and Naoki Miyamoto.<\/li>
        22. \u65e5\u672c\u539f\u5b50\u529b\u5b66\u4f1a\u5317\u6d77\u9053\u652f\u90e8\u7b2c40\u56de\u7814\u7a76\u767a\u8868\u4f1a\uff0c\u30b9\u30ad\u30e3\u30cb\u30f3\u30b0\u967d\u5b50\u7dda\u6cbb\u7642\u3092\u9069\u7528\u3057\u305f\u809d\u81d3\u304c\u3093\u306b\u304a\u3051\u308b\u4e9c\u81f4\u6b7b\u640d\u50b7\u4fee\u5fa9\u306e\u6291\u5236\u306e\u305f\u3081\u306e\u7dda\u91cf\u6642\u9593\u69cb\u9020\u5909\u8abf\u6cd5\uff0c\u4e95\u4e0a\u7fd4\uff0c\u7b20\u677e\u5e78\u751f\uff0c\u7d30\u4e95\u5149\uff0c\u9ad8\u5c3e\u8056\u5fc3\uff0c\u5bae\u672c\u76f4\u6a39\uff0c\u9673\u53f6\uff0c\u6a2a\u5ddd\u822a\u5e73\uff0c\u677e\u6d66\u5999\u5b50<\/li>
        23. \u65e5\u672c\u539f\u5b50\u529b\u5b66\u4f1a\u5317\u6d77\u9053\u652f\u90e8\u7b2c40\u56de\u7814\u7a76\u767a\u8868\u4f1a\uff0c\u967d\u5b50\u7dda\u6cbb\u7642\u306b\u304a\u3051\u308b\u30dc\u30ea\u30e5\u30fc\u30e0\u30b2\u30fc\u30c6\u30a3\u30f3\u30b0\u7167\u5c04\u306e\u6709\u52b9\u6027\u8a55\u4fa1\uff0c\u9577\u5185\u548c\u4ec1\uff0c\u9ad8\u5c3e\u8056\u5fc3\uff0c\u9673\u53f6\uff0c\u6a2a\u5ddd\u822a\u5e73\uff0c\u677e\u6d66\u5999\u5b50\uff0c\u5bae\u672c\u76f4\u6a39<\/li>
        24. \u5c0f\u6a4b\u5553\u53f8, \u897f\u5ca1\u5065\u592a\u90ce, \u6a4b\u672c\u5b5d\u4e4b, \u7530\u6751\u5f18\u8a5e, \u4e2d\u91cc\u6167\u4e8c, \u7530\u53e3\u5927\u5fd7, \u5b89\u7530\u8015\u4e00, \u6253\u6d6a\u96c4\u4ecb, \u52a0\u85e4\u5fb3\u96c4, \u9752\u5c71\u82f1\u53f2: \u65e5\u3005CT\u753b\u50cf\u3092\u7528\u3044\u3066\u9069\u5fdc\u967d\u5b50\u7dda\u6cbb\u7642\u306b\u304a\u3051\u308b\u65e5\u3005\u7dda\u91cf\u5206\u5e03\u3092\u8fc5\u901f\u8a55\u4fa1\u3059\u308b\u30b7\u30b9\u30c6\u30e0\u306e\u958b\u767a, \u7b2c2\u56de\u65e5\u672c\u91cf\u5b50\u533b\u79d1\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a,\u3000\u7b51\u6ce2, 2022<\/li>
        25. \u5c0f\u6a4b\u5553\u53f8, \u897f\u5ca1\u5065\u592a\u90ce, \u6a4b\u672c\u5b5d\u4e4b, \u7530\u6751\u5f18\u8a5e, \u4e2d\u91cc\u6167\u4e8c, \u7530\u53e3\u5927\u5fd7, \u5b89\u7530\u8015\u4e00, \u6253\u6d6a\u96c4\u4ecb, \u52a0\u85e4\u5fb3\u96c4, \u9752\u5c71\u82f1\u53f2: \u9069\u5fdc\u967d\u5b50\u7dda\u6cbb\u7642\u306b\u304a\u3051\u308b\u65e5\u3005\u306e\u7dda\u91cf\u5206\u5e03\u306e\u8fc5\u901f\u8a55\u4fa1\u30b7\u30b9\u30c6\u30e0\u306e\u958b\u767a, \u7b2c36\u56de\u9ad8\u7cbe\u5ea6\u653e\u5c04\u7dda\u5916\u90e8\u7167\u5c04\u90e8\u4f1a\u5b66\u8853\u5927\u4f1a,\u3000\u67cf, 2023<\/li>
        26. \u7b2c7\u56de\u65e5\u672c\u7a7f\u523a\u30c9\u30ec\u30ca\u30fc\u30b8\u7814\u7a76\u4f1a\u3001\u5927\u962a\u5e02\u30012022.7.16
          \u963f\u4fdd\u5927\u4ecb\uff0c\u5b89\u4e95\u592a\u4e00\uff0c\u68ee\u7530\u4eae\uff0c\u9ad8\u6a4b\u6587\u4e5f\uff0c\u6728\u91ce\u7530\u76f4\u4e5f\uff0c\u52a0\u85e4\u5927\u7950, \u85e4\u4e95\u5b9d\u9855,
          \u91ce\u8def\u6b66\u5bdb,\u3000\u5e73\u91ce\u8061, \u5de5\u85e4\u8207\u4eae\uff1a\u809d\u5207\u9664\u8853\u5f8c\u306b\u5408\u4f75\u3057\u305f\u96e3\u6cbb\u6027\u80c6\u6c41\u763b\u306b\u5bfe\u3059\u308bNBCA\u3092\u7528\u3044\u305f\u7d4c\u76ae\u7684\u80c6\u7ba1\u713c\u707c\u8853\u306e\u7d4c\u9a13<\/li>
        27. \u7b2c76\u56de\u5317\u6d77\u9053\u8840\u7ba1\u9020\u5f71Interventional Radiology\u7814\u7a76\u4f1a\u3001\u672d\u5e4c\u5e02\u30012022.8.27
          \u963f\u4fdd\u5927\u4ecb\u3001\u68ee\u7530\u4eae\u3001\u9ad8\u6a4b\u6587\u4e5f\u3001\u52a0\u85e4\u5927\u7950\u3001\u6728\u91ce\u7530\u76f4\u4e5f\u3001\u85e4\u4e95\u5b9d\u9855\u3001\u5de5\u85e4\u8207\u4eae\uff1a\u89e3\u96e2\u6027\u809d\u52d5\u8108\u7624\u306b\u5bfe\u3059\u308b\u52d5\u8108\u585e\u6813\u8853<\/li>
        28. \u7b2c76\u56de\u5317\u6d77\u9053\u8840\u7ba1\u9020\u5f71Interventional Radiology\u7814\u7a76\u4f1a\u3001\u672d\u5e4c\u5e02\u30012022.8.27
          \u52a0\u85e4\u5927\u7950\u3001\u963f\u4fdd\u5927\u4ecb\u3001\u9ad8\u6a4b\u6587\u4e5f\u3001\u68ee\u7530\u4eae\u3001\u6728\u91ce\u7530\u76f4\u4e5f\u3001\u85e4\u4e95\u5b9d\u9855\u3001\u5de5\u85e4\u8207\u4eae\u3001\u7af9\u5185\u614e\u592a\u90ce\u3001\u6d45\u91ce\u8ce2\u9053\u3001\u5e73\u91ce\u8061\uff1aTAE\u56f0\u96e3\u306a\u809d\u4eee\u6027\u52d5\u8108\u7624\u306b\u5bfe\u3059\u308b\u7d4c\u76ae\u7684\u76f4\u63a5\u7a7f\u523a\u585e\u6813\u8853<\/li>
        29. Japan\u3000Peripheral\u3000Embolization\u3000Conference\u3001\u5ddd\u5d0e\u5e02\uff08\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9\u958b\u50ac\uff09\u30012022.10.15
          \u68ee\u7530\u4eae, \u963f\u4fdd\u5927\u4ecb, \u66fd\u5c71\u6b66\u58eb, \u4eca\u4e95\u54f2\u79cb, \u9ad8\u6a4b\u6587\u4e5f, \u5409\u91ce\u88d5\u7d00, \u6728\u91ce\u7530\u76f4\u4e5f, \u52a0\u85e4\u5927\u7950, \u85e4\u4e95\u5b9d\u9855 \u5de5\u85e4\u8207\u4eae\uff1a\u9ad8\u7cbe\u7d303D\u8840\u7ba1\u30e2\u30c7\u30eb\u3092\u7528\u3044\u305f\u8853\u524d\u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u306e\u6709\u7528\u6027\uff1a\u9ad8\u6d41\u91cf\u814e\u52d5\u9759\u8108\u763b\u306b\u5bfe\u3057\u3066Preloading coil-in-plug\u6cd5\u304c\u594f\u52b9\u3057\u305f2\u75c7\u4f8b<\/li>
        30. \u7b2c30\u56de \u65e5\u672c\u4e73\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\u3001\u6a2a\u6d5c\uff08\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9\u958b\u50ac\uff09\u30012022.6.30-7.2
          \u52a0\u85e4\u6276\u7f8e\u3000\u4f50\u85e4\u6075\u7f8e\u3000\u897f\u7530\u7766\u3000\u7af9\u4e0b\u5353\u5fd7\u3000\u62bc\u91ce\u667a\u535a\u3000\u5e38\u7530\u6167\u5fb3\u3000\u5b88\u8c37\u7d50\u7f8e\u3000\u4e0a\u77f3\u5d07\u53f2 \u6852\u5c71\u771f\u7d00\u3000\u9ad8\u6a4b \u5c07\u4eba \u5de5\u85e4\u8207\u4eae\uff1a\u4e73\u623f\u5c02\u7528\u8d85\u97f3\u6ce2CT\u306b\u3088\u308b\u4e73\u764c\u691c\u51fa\u80fd\u306e\u691c\u8a0e<\/li>
        31. \u6589\u85e4\u9053\u7d00, \u52a0\u85e4\u5343\u6075\u6b21. \u30c7\u30a3\u30fc\u30d7\u30e9\u30fc\u30cb\u30f3\u30b0\u306b\u3088\u308b\u975e\u6e1b\u5f31\u88dc\u6b63PET\u753b\u50cf\u3092\u7528\u3044\u305f\u6e1b\u5f31\u88dc\u6b63\u7528CT\u50cf\u306e\u63a8\u5b9a. \u7b2c42\u56de\u65e5\u672c\u6838\u533b\u5b66\u6280\u8853\u5b66\u4f1a\u7dcf\u4f1a\u5b66\u8853\u5927\u4f1a\u3001\u4eac\u90fd\u5e02 2022.9<\/li>
        32. \u897f\u4e0a\u5065\u592a\u6717, \u9f4a\u85e4\u9053\u7d00, \u52a0\u85e4\u5343\u6075\u6b21. GAN\u3092\u5229\u7528\u3057\u305fPET\u6e1b\u5f31\u88dc\u6b63\u306b\u95a2\u3059\u308b\u691c\u8a0e. \u7b2c42\u56de\u65e5\u672c\u6838\u533b\u5b66\u6280\u8853\u5b66\u4f1a\u7dcf\u4f1a\u5b66\u8853\u5927\u4f1a\u3001\u4eac\u90fd\u5e02 2022.9<\/li>
        33. \u524d\u5ddd\u6953\u7a00, \u52a0\u85e4\u5343\u6075\u6b21. 18F-FDG\u30c0\u30a4\u30ca\u30df\u30c3\u30af\u8133PET\u691c\u67fb\u306b\u304a\u3051\u308bCNN\u3092\u7528\u3044\u305fCMRGlc(\u8133\u5c40\u6240\u7cd6\u4ee3\u8b1d)\u306e\u63a8\u5b9a. \u7b2c42\u56de\u65e5\u672c\u6838\u533b\u5b66\u6280\u8853\u5b66\u4f1a\u7dcf\u4f1a\u5b66\u8853\u5927\u4f1a, \u4eac\u90fd\u5e02 2022.9<\/li>
        34. \u5965\u6751\u8129\u4e00\u90ce, \u52a0\u85e4\u5343\u6075\u6b21. CNN\u306b\u3088\u308b15O-CO2\u30c0\u30a4\u30ca\u30df\u30c3\u30af\u8133PET\u306e\u975e\u4fb5\u8972\u7684\u306a\u5165\u529b\u95a2\u6570\u63a8\u5b9a. \u7b2c42\u56de\u65e5\u672c\u6838\u533b\u5b66\u6280\u8853\u5b66\u4f1a\u7dcf\u4f1a\u5b66\u8853\u5927\u4f1a, \u4eac\u90fd\u5e02 2022.9<\/li>
        35. \u5965\u6751\u8129\u4e00\u90ce, \u52a0\u85e4\u5343\u6075\u6b21, \u9ad9\u6728\u8000\u4ecb, \u5b6b\u7530\u60e0\u4e00, \u5e73\u7530\u5065\u53f8. 15O-CO2 \u30c0\u30a4\u30ca\u30df\u30c3\u30af\u8133PET\u691c\u67fb\u306b\u304a\u3051\u308b\u975e\u4fb5\u8972\u7684\u306a\u5165\u529b\u95a2\u6570\u306e\u63a8\u5b9a. \u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a \u7b2c78\u56de\u7dcf\u4f1a\u5b66\u8853\u5927\u4f1a, \u6a2a\u6d5c 2022.4<\/li>
        36. \u9f4b\u85e4\u9053\u7d00, \u897f\u4e0a\u5065\u592a\u6717, \u52a0\u85e4\u5343\u6075\u6b21, \u5e73\u7530\u5065\u53f8, \u5b6b\u7530\u60e0\u4e00. \u975e\u6e1b\u5f31\u88dc\u6b63PET\u753b\u50cf\u304b\u3089\u306e\u30c7\u30a3\u30fc\u30d7\u30e9\u30fc\u30cb\u30f3\u30b0\u306b\u3088\u308b\u7dda\u6e1b\u5f31\u4fc2\u6570\u7528CT\u50cf\u306e\u63a8\u5b9a. \u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a \u7b2c78\u56de\u7dcf\u4f1a\u5b66\u8853\u5927\u4f1a\u3001\u6a2a\u6d5c 2022.4<\/li>
        37. \u897f\u4e0a\u5065\u592a\u6717, \u9f4b\u85e4\u9053\u7d00, \u52a0\u85e4\u5343\u6075\u6b21, \u5b6b\u7530\u60e0\u4e00, \u5e73\u7530\u5065\u53f8. \u975e\u6e1b\u5f31\u88dc\u6b63PET\u753b\u50cf\u304b\u3089\u306eGAN\u3092\u7528\u3044\u305f\u6e1b\u5f31\u88dc\u6b63PET\u753b\u50cf\u306e\u63a8\u5b9a. \u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a \u7b2c78\u56de\u7dcf\u4f1a\u5b66\u8853\u5927\u4f1a\u3001\u6a2a\u6d5c 2022.4<\/li>
        38. \u4e45\u4e0b \u88d5\u53f8\uff1a\u6838\u533b\u5b66\u6cbb\u7642\u7528\u6838\u7a2e\u30fb\u85ac\u5264\u306e\u57fa\u790e\u3068\u5c55\u958b\u3002\u30b7\u30f3\u30dd\u30b8\u30a6\u30e051 \u500b\u5225\u5316\u533b\u7642\u3092\u63a8\u9032\u3059\u308b\u6838\u533b\u5b66\u8a3a\u7642\u7528\u653e\u5c04\u6027\u533b\u85ac\u54c1\u3002\u7b2c32\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a\u3001G \u30e1\u30c3\u30bb\u7fa4\u99ac\u30fb\u9ad8\u5d0e\u82b8\u8853\u5287\u5834\u3001\u9ad8\u5d0e\u30012022\u5e749\u670823\u65e5\uff5e25\u65e5<\/li>
        39. \u4e2d\u5cf6 \u5b5d\u5e73\u3001\u672c\u9593 \u5145\u61b2\u3001\u9234\u6728 \u57fa\u53f2\u3001\u6a2a\u5185 \u52c7\u592a\u3001\u677e\u7530 \u62d3\u771f\u3001\u9ad8\u5009 \u6804\u7537\u3001\u5e73\u7530 \u5065\u53f8\u3001\u4e45\u4e0b \u88d5\u53f8\u3001\u5c0f\u5ddd \u7f8e\u9999\u5b50\uff1a\u6297PD-1\u6297\u4f53\u304c\u816b\u760d\u5185\u306e\u4f4e\u9178\u7d20\u72b6\u614b\u306b\u53ca\u307c\u3059\u5f71\u97ff\u306b\u95a2\u3059\u308b\u4f4e\u9178\u7d20PET\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u5264\u3092\u7528\u3044\u305f\u691c\u8a0e\u3002\u7b2c34\u56de \u30d0\u30a4\u30aa\u30e1\u30c7\u30a3\u30ab\u30eb\u5206\u6790\u79d1\u5b66\u30b7\u30f3\u30dd\u30b8\u30a6(BMAS2022)\u3001\u65e5\u672c\u5927\u5b66\u85ac\u5b66\u90e8\u3001\u8239\u6a4b\u30012022\u5e749\u67082\u65e5\uff5e3\u65e5<\/li>
        40. \u83ca\u6c60\u5eb7\u5b50\u3001\u6c34\u91ce\u96c4\u8cb4\u3001\u591a\u7530\u54f2\u6717\u3001\u5bcc\u7530\u7fd4\u3001\u7530\u6ca2\u5468\u4f5c\u3001\u9df2\u91ce\u5f18\u660e\u3001\u83c5\u539f\u96c4\u4e00\u90ce\u3001\u4e45\u4e0b\u88d5\u53f8\uff1a\u81ea\u52d5\u5408\u6210\u88c5\u7f6e\u3067\u88fd\u9020\u3057\u305f68Ga-PSMA-11 \u6ce8\u5c04\u6db2\u306b\u542b\u307e\u308c\u308b\u4e0d\u7d14\u7269\u3002\u7b2c62\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\u3001\u56fd\u7acb\u4eac\u90fd\u56fd\u969b\u4f1a\u9928\u3001\u4eac\u90fd\u30012022\u5e749\u67089\u65e5\uff5e11\u65e5<\/li>
        41. \u591a\u7530 \u54f2\u6717\u3001\u6c34\u91ce \u96c4\u8cb4\u3001\u67f4\u7530 \u60a0\u8cb4\u3001\u5b89\u4e95 \u535a\u5ba3\u3001\u4e45\u4e0b \u88d5\u53f8\uff1aROS\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u76ee\u7684\u3068\u3057\u305f[64Cu]Cu+\u932f\u4f53\u306e\u5408\u6210\u3068\u8a55\u4fa1\uff1a\u914d\u4f4d\u5b50\u69cb\u9020\u304c\u932f\u4f53\u306e\u5b89\u5b9a\u6027\u306b\u4e0e\u3048\u308b\u5f71\u97ff\u3002\u7b2c62\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\u3001\u56fd\u7acb\u4eac\u90fd\u56fd\u969b\u4f1a\u9928\u3001\u4eac\u90fd\u30012022\u5e749\u67089\u65e5\uff5e11\u65e5<\/li>
        42. \u591a\u7530 \u54f2\u6717\u3001\u6c34\u91ce \u96c4\u8cb4\u3001\u67f4\u7530 \u60a0\u8cb4\u3001\u5b89\u4e95 \u535a\u5ba3\u3001\u4e45\u4e0b \u88d5\u53f8\uff1a\u30ec\u30c9\u30c3\u30af\u30b9\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u76ee\u7684\u3068\u3057\u305f[64Cu][CuI(BCS)2]+\u306e\u5408\u6210\u3068ROS\u3068\u306e\u53cd\u5fdc\u6027\u8a55\u4fa1\u3002\u7b2c5\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5206\u79d1\u4f1a \u653e\u5c04\u6027\u85ac\u54c1\u79d1\u5b66\u7814\u7a76\u4f1a\u3001\u30cf\u30d4\u30ea\u30f3\u30db\u30fc\u30eb\u3001\u798f\u4e95\u30012022\u5e749\u670817\u65e5<\/li>
        43. \u6797 \u9f8d\u6615\u3001\u6c34\u91ce \u96c4\u8cb4\u3001\u67f4\u7530 \u60a0\u8cb4\u3001\u5b89\u4e95 \u535a\u5ba3\u3001\u4e45\u4e0b \u88d5\u53f8\uff1aCystine-dense peptide\u3092\u6bcd\u4f53\u3068\u3057\u305fTfR1\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u85ac\u5264\u958b\u767a\u306b\u5411\u3051\u305f\u57fa\u790e\u7684\u691c\u8a0e\u3002\u7b2c8\u56de \u5317\u5927\u30fb\u90e8\u5c40\u6a2a\u65ad\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3001\u5317\u6d77\u9053\u5927\u5b66\u3001\u672d\u5e4c\u30012022\u5e7410\u670828\u65e5<\/li>
        44. \u5409\u4e95\u52c7\u6cbb\u3001\u963f\u4fdd\u61b2\u53f2\u3001\u6c34\u91ce\u96c4\u8cb4\u3001\u4e45\u4e0b\u88d5\u53f8\uff1a\u03b2\u7dda\u88ab\u3070\u304f\u306b\u5bfe\u3059\u308b\u653e\u5c04\u7dda\u6559\u80b2\u3092\u652f\u63f4\u3059\u308b\u6559\u6750\u306e\u958b\u767a\u3002\u7b2c4\u56de\u65e5\u672c\u4fdd\u5065\u7269\u7406\u5b66\u4f1a\u30fb\u65e5\u672c\u653e\u5c04\u7dda\u5b89\u5168\u7ba1\u7406\u5b66\u4f1a\u5408\u540c\u5927\u4f1a\u3001\u4e5d\u5dde\u5927\u5b66\u690e\u6728\u8b1b\u5802\u3001\u798f\u5ca1\u5e02\u30012022\u670811\u65e524\uff5e26\u65e5<\/li>
        45. \u963f\u4fdd\u61b2\u53f2\u3001\u5409\u4e95\u52c7\u6cbb\u3001\u6c34\u91ce\u96c4\u8cb4\u3001\u4e45\u4e0b\u88d5\u53f8\uff1a\u591a\u76ee\u7684\u7528\u9014\u306b\u4f7f\u7528\u53ef\u80fd\u306a\u653e\u5c04\u7dda\u6e2c\u5b9a\u6821\u6b63\u7528\u6cbb\u5177\u306e\u958b\u767a\u3002\u7b2c4\u56de\u65e5\u672c\u4fdd\u5065\u7269\u7406\u5b66\u4f1a\u30fb\u65e5\u672c\u653e\u5c04\u7dda\u5b89\u5168\u7ba1\u7406\u5b66\u4f1a\u5408\u540c\u5927\u4f1a\u3001\u4e5d\u5dde\u5927\u5b66\u690e\u6728\u8b1b\u5802\u3001\u798f\u5ca1\u5e02\u30012022\u670811\u65e524\uff5e26\u65e5<\/li>
        46. \u963f\u4fdd\u61b2\u53f2\u3001\u6c34\u91ce\u96c4\u8cb4\u3001\u5409\u4e95\u52c7\u6cbb\u3001\u4e45\u4e0b\u88d5\u53f8\uff1a\u8996\u899a\u7684\u52b9\u679c\u3092\u4ed8\u4e0e\u3057\u305fRI-web\u6559\u6750\u306e\u958b\u767a\u3002\u7b2c4\u56de\u65e5\u672c\u4fdd\u5065\u7269\u7406\u5b66\u4f1a\u30fb\u65e5\u672c\u653e\u5c04\u7dda\u5b89\u5168\u7ba1\u7406\u5b66\u4f1a\u5408\u540c\u5927\u4f1a\u3001\u4e5d\u5dde\u5927\u5b66\u690e\u6728\u8b1b\u5802\u3001\u798f\u5ca1\u5e02\u30012022\u670811\u65e524\uff5e26\u65e5<\/li>
        47. \u6797 \u9f8d\u6615\u3001\u6c34\u91ce \u96c4\u8cb4\u3001\u4e45\u4e0b \u88d5\u53f8\u3001\u67f4\u7530 \u60a0\u8cb4\u3001\u5b89\u4e95 \u535a\u5ba3\uff1aCystine-dense peptide TfRB1G3 \u306eTfR1\u3078\u306e\u89aa\u548c\u6027\u8a55\u4fa1\u306868Ga\u6a19\u8b58\u306b\u5411\u3051\u305fHBED-CC\u7d50\u5408\u4f53\u306e\u5408\u6210\u3002\u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c143\u5e74\u4f1a\u3001\u5317\u6d77\u9053\u5927\u5b66\u3001\u672d\u5e4c\u30012023\u5e743\u670826\uff5e28\u65e5<\/li>
        48. \u6c34\u91ce \u96c4\u8cb4\u3001\u5c3e\u6c5f \u609f\u3001\u5bbf\u91cc \u5145\u7a57\u3001\u79cb\u6fa4 \u5b8f\u884c\u3001\u4e45\u4e0b \u88d5\u53f8\uff1a\u591a\u4fa1RGD\u30da\u30d7\u30c1\u30c9\u304c\u8907\u6570\u306eintegrin \u03b1v\u03b23\u3068\u540c\u6642\u7d50\u5408\u3059\u308b\u305f\u3081\u306b\u91cd\u8981\u306a\u5316\u5b66\u69cb\u9020\u306e\u63a2\u7d22\u3002\u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c143\u5e74\u4f1a\u3001\u5317\u6d77\u9053\u5927\u5b66\u3001\u672d\u5e4c\u30012023\u5e743\u670826\uff5e28\u65e5<\/li>
        49. \u6749\u7530\u8309\u592e\u3001\u5c3e\u6c5f\u609f\u3001\u5927\u4e95\u4e00\u751f\u3001\u718a\u5ddd\u7531\u5229\u9999\u3001\u91d1\u5b50\u745e\u5e0c\u3001\u6c34\u91ce\u96c4\u8cb4\u3001\u5bbf\u91cc\u5145\u7a57\u3001\u79cb\u6fa4\u5b8f\u884c\uff1a\u5c0e\u5165\u3057\u305fRGD\u30da\u30d7\u30c1\u30c9\u306e\u6570\u304c\u30a2\u30eb\u30d6\u30df\u30f3\u4e8c\u91cf\u4f53\u306e\u4f53\u5185\u52d5\u614b\u6319\u52d5\u306b\u53ca\u307c\u3059\u5f71\u97ff\u3002\u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c143\u5e74\u4f1a\u3001\u5317\u6d77\u9053\u5927\u5b66\u3001\u672d\u5e4c\u30012023\u5e743\u670826\uff5e28\u65e5<\/li>
        50. \u5927\u5ead \u681e\u3001\u5c3e\u6c5f \u609f\u3001\u9ad8\u5802 \u6b4c\u97f3\u3001\u6c34\u91ce \u96c4\u8cb4\u3001\u5bbf\u91cc \u5145\u7a57\u3001\u79cb\u6fa4 \u5b8f\u884c\uff1aGlyoxalase I\u6a19\u7684\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u30d7\u30ed\u30fc\u30d6\u306e\u958b\u767a\u7814\u7a76: \u653e\u5c04\u6027\u30e8\u30a6\u7d20\u5c0e\u5165\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\u985e\u4f3c\u4f53\u306e\u30b8\u30a8\u30b9\u30c6\u30eb\u306e\u7d30\u80de\u5185\u4ee3\u8b1d\u6319\u52d5\u306b\u95a2\u3059\u308b\u691c\u8a0e\u3002\u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c143\u5e74\u4f1a\u3001\u5317\u6d77\u9053\u5927\u5b66\u3001\u672d\u5e4c\u30012023\u5e743\u670826\uff5e28\u65e5<\/li>
        51. \u6df1\u5c64\u5b66\u7fd2\u3092\u7528\u3044\u305f\u8133\u6897\u585e\u9818\u57df\u62bd\u51fa\u306b\u304a\u3051\u308b\u6559\u5e2b\u753b\u50cf\u306e\u5de5\u592b\u306b\u3088\u308b\u8a55\u4fa1\u6307\u6a19\u306e\u6bd4\u8f03
          \u68ee\u8c37 \u7adc\u99ac, \u5409\u6751 \u9ad8\u660e, \u5510 \u660e\u8f1d, \u6749\u68ee \u535a\u884c
          \u7b2c78\u56de\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u5317\u6d77\u9053\u652f\u90e8\u79cb\u5b63\u5927\u4f1a 2022\u5e7411\u6708 (\u672d\u5e4c\u5e02)<\/li>
        52. cine-MRI\u3092\u7528\u3044\u305f3D-CNN\u306b\u3088\u308b\u5de6\u5ba4\u99c6\u51fa\u7387\u3068\u53f3\u5ba4\u99c6\u51fa\u7387\u63a8\u5b9a
          \u732a\u80a1 \u58ee\u4e00\u90ce, \u5409\u6751 \u9ad8\u660e, \u5510 \u660e\u8f1d, \u6749\u68ee \u535a\u884c
          \u7b2c78\u56de\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u5317\u6d77\u9053\u652f\u90e8\u79cb\u5b63\u5927\u4f1a 2022\u5e7411\u6708 (\u672d\u5e4c\u5e02)<\/li>
        53. Deep Learning\u6280\u8853\u3092\u7528\u3044\u305f\u8133MRI\u753b\u50cf\u306b\u3088\u308b\u30d2\u30c8\u306e\u5e74\u9f62\u63a8\u5b9a\u624b\u6cd5\u306e\u691c\u8a0e
          \u8584\u4e95 \u5eb7\u8f14, \u5409\u6751 \u9ad8\u660e, \u5510 \u660e\u8f1d, \u6749\u68ee \u535a\u884c
          \u7b2c50\u56de\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u79cb\u5b63\u5b66\u8853\u5927\u4f1a 2022\u5e7410\u6708 (\u6771\u4eac\u90fd\u58a8\u7530\u533a)<\/li>
        54. 3D-Convolutional Neural Network(CNN)\u306b\u3088\u308b\u56de\u5e30\u3092\u7528\u3044\u305f\u5de6\u5ba4\u99c6\u51fa\u7387\u4e88\u6e2c\u306b\u95a2\u3059\u308b\u691c\u8a0e
          \u732a\u80a1 \u58ee\u4e00\u90ce, \u5409\u6751 \u9ad8\u660e, \u5510 \u660e\u8f1d, \u6749\u68ee \u535a\u884c
          \u7b2c50\u56de\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u79cb\u5b63\u5b66\u8853\u5927\u4f1a 2022\u5e7410\u6708 (\u6771\u4eac\u90fd\u58a8\u7530\u533a)<\/li>
        55. Improvement of accuracy in evaluating cerebral arteriolar vasomotor function using MRI
          Masaya Kubota, Hiroyuki Sugimori, Takaaki Yoshimura, Minghui Tang
          \u7b2c50\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a\u30002022\u5e749\u6708 (\u540d\u53e4\u5c4b\u5e02)<\/li>
        56. Electromagnetic field simulation analysis of MRI burn accident due to thigh contact
          Kaito Yamashita, Takaaki Yoshimura, Hiroyuki Sugimori, Minghui Tang
          \u7b2c50\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a\u30002022\u5e749\u6708 (\u540d\u53e4\u5c4b\u5e02)<\/li>
        57. Assessment of collagen fiber orientation in mouse femur using UTE signal
          Daisuke Sato, Ken Masuyama, Yudai Abe, Takaaki Yoshimura, Hiroyuki Sugimori, Minghui Tang
          \u7b2c50\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a\u30002022\u5e749\u6708 (\u540d\u53e4\u5c4b\u5e02)<\/li>
        58. Mapping of rheumatoid arthritis hand synovitis on DCE-MRI with deep learning classification of time-intensity curve (TIC) shapes
          Wanxuan Fang, Yujie An, Hiroyuki Sugimori, Shinji Kiuch, Tamotsu Kamishima
          \u7b2c50\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a\u30002022\u5e749\u6708 (\u540d\u53e4\u5c4b\u5e02)<\/li>
        59. The Usefulness of the Montage Method in the Classification of Brain MRI of Patients Suspected Acute Ischemic Stroke using Convolution Neural Network
          Daisuke Oura, Hiroyuki Sugimori
          \u7b2c50\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a\u30002022\u5e749\u6708 (\u540d\u53e4\u5c4b\u5e02)<\/li>
        60. \u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u60a3\u8005\u306e\u6ed1\u819c\u708e\u3092\u81ea\u52d5\u3067\u62bd\u51fa\u3059\u308b\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u306e\u958b\u767a-\u624b\u306e\u30c0\u30a4\u30ca\u30df\u30c3\u30afMRI\u3092\u7528\u3044\u305f\u691c\u8a0e
          Wanxuan Fang, Yujie An, Hiroyuki Sugimori, Shinji Kiuch, Tamotsu Kamishima
          \u7b2c 81 \u56de \u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a2022\u5e744\u6708 (\u6a2a\u6d5c\u5e02)<\/li>
        61. \u982d\u90e8\u5358\u7d14CT\u64ae\u5f71\u306b\u304a\u3051\u308b\u7269\u4f53\u691c\u51fa\u6280\u8853\u3092\u7528\u3044\u305f\u591a\u6bb5\u9762\u518d\u69cb\u6210\u753b\u50cf\u306e\u81ea\u52d5\u751f\u6210
          \u5e02\u5ddd \u7fd4\u592a, \u5c71\u672c \u6d69\u4e4b, \u677f\u8c37 \u82f1\u6a39, \u6749\u68ee \u535a\u884c
          \u7b2c78\u56de\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u7dcf\u4f1a\u5b66\u8853\u5927\u4f1a2022\u5e744\u6708 (\u6a2a\u6d5c\u5e02)<\/li>
        62. Kitagawa M, Sawamura D, Urushibata Y, Hamaguchi H, Tha KK. The effect of short-term nocturnal wakefulness on the brain (in Japanese). The 8th Hokkaido University Cross-Departmental Symposium (Hybrid\/ Sapporo).<\/li><\/ol>

          Other Presentations [International Conference]\uff1a\u5b66\u4f1a\u767a\u8868(\u56fd\u969b)<\/h3>
          1. Nishioka K\uff1a American Society of Radiation Oncology Annual meeting 2022(2022\/10\/23-26)
            \u300cA single-institution prospective study to evaluate the safety and efficacy of Real-time-image Gated spot-scanning Proton Therapy (RGPT) for prostate cancer\u300d
            K. Nishioka, T. Hashimoto, T. Mori, Y. Uchinami, R. Kinoshita, N. Katoh, H. Taguchi, K. Yasuda, S. Takahashi, Y. M. Ito, S. Takao, M. Tamura, S. Shimizu, H. Shirato, H. Aoyama<\/li>
          2. Nishioka K\uff1aThe 9th GCB Biomedical Science and Engineering Symposium(2022\/8\/20)
            \u300cValidation of the Lung-molGPA for Japanese NSCLC patients with brain metastases\u300d
            Kentaro Nishioka, Hajime Higaki, Manami Otsuka, Noboru Nishikawa, Motoyasu Shido, Hideki Minatogawa, Yukiko Nishikawa, Rikiya Takashina, Takayuki Hashimoto, Norio Katoh, Hiroshi Taguchi, Rumiko Kinoshita, Koichi Yasuda, Takashi Mori, Yusuke Uchinami, Fuki Koizumi, Yoshihiro Fujita, Shuhei Takahashi, Takahiro Hattori, Noriaki Nishiyama, Hidefumi Aoyama<\/li>
          3. SNMMI 2022, Vancouver, Canada, 2022.6.11-14
            Hirata K, Watanabe S, Takenaka J, Kimura R, Uchiyama Y, Magota K, Kudo K: Combination of image and its report of FDG-PET\/CT to generate probability map of anatomical terms using SUVmax as a bridge between text and image.<\/li>
          4. SNMMI 2022, Vancouver, Canada, 2022.6.11-14
            Kimura R, Hirata K, Watanabe S, Uchiyama Y, Takenaka J, Kudo K: Composing a dictionary of lesions showing SUVmax greater than 20: an exhaustive, computer-assisted study<\/li>
          5. SNMMI 2022, Vancouver, Canada, 2022.6.11-14
            Takenaka J, Watanabe S, Abe T, Hirata K, Uchiyama Y, Kimura R, Shinohara N, Kudo K: FDG PET as a prognostic biomarker for unresectable PPGL treated with I-131 MIBG radiotherapy.<\/li>
          6. CIRSE 2022, Barcelona, Spain, 2022.9.10-14
            Kinota N, Abo D, Suzuki J, Takahashi B, Yasui T, Morita R, Soyama T, Kimura T, Sakuhara Y, Kudo K: The Efficacy of Post-operative Portal Venous Stenting: With Special Reference to Improvement of Serum Albumin Level.<\/li>
          7. JSIR, ISIR & APSCVIR 2022 \u7b2c51\u56de\u65e5\u672cIVR\u5b66\u4f1a\u7dcf\u4f1a, Kobe, Japan\uff08\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9\u958b\u50ac\uff09, 2022.6.4-7
            Abo D\uff0cSoyama T\uff0cMorita R\uff0cTakahashi B\uff0cKinota N, Yasui T, Kudo K : A case of transarterial and transvenous embolization of ruptured renal arteriovenous malformation<\/li>
          8. JSIR, ISIR & APSCVIR 2022, Kobe, Japan, 2022.6.4-6
            Yasui T, Abo D, Soyama T, Morita R, Takahashi B, Kinota N, Noji T, Hirano T, Kudo K: A case of bile duct ablation with N-butyl cyanoacrylate for isolated bile leakage after hepatectomy<\/li>
          9. JSIR,ISIR & APSCVIR 2022, Kobe, Japan, 2022.6.4-6
            Kinota N, Abo D, Ishizaka K, Tsuneta S, Takahashi B, Yasui T, Morita R, Soyama T, Kudo K: Evaluation of Portal Venous Flow with 4D-flow MRI Before and After Partial Splenic Embolization.<\/li>
          10. \u00a0Ochiai A, Katoh C. Improvement of the detectability of perfusable tissue fraction and myocardial flow reserve after revascularization by 15O-water ECG-gated PET. Annual Congress of the European Association of Nuclear Medicine (EANM), Barcelona, Spain 2022.10<\/li>
          11. Kentaro Nishigami K, Saito M, Katoh C. Estimating attenuation-corrected PET images using GAN from non-attenuation-corrected PET images. Annual Congress of the European Association of Nuclear Medicine (EANM), Barcelona, Spain 2022.10<\/li>
          12. \u00a0Saito M, Nishigami K, Katoh C. Estimation of CT images from PET images without non-attenuation-corrected PET images using GAN. Annual Congress of the European Association of Nuclear Medicine (EANM), Barcelona, Spain 2022.10<\/li>
          13. Nakajima K, Homma M Suzuki M, Yokouchi Y, Matsuda T, Takakura H, Hirata K, Kuge Y, Ogawa M: Anti-PD-1 therapy reduces tumor hypoxia: evaluation with pimonidazole and [18F]fluoromisonidazole as hypoxia probes. AACR ANNUAL MEETING 2022, Ernest N. Morial Convention Center, New Orleans, LA. 2022. 04.08 \u2013 13.<\/li>
          14. Ueno S, Some K, Oda T, Guerra F, Takahashi K, Nishijima K, Higuchi H, Shiga T, Kuge Y: Development of a high-yield and clinical grade cyclotron based 68Ga-PSMA-11 production system. The 13th Congress of the World Federation of Nuclear Medicine and Biology (WFNMB2022), Kyoto International Conference Center, Kyoto, Japan. 2022.09.07-11.<\/li>
          15. Mizuno Y, Kimura K, Onoe S, Shukuri M, Kuge Y, Akizawa H: Development of 99mTc-labeled hexavalent c(RGDfK) peptide with optimized linker structure for in vivo imaging of integrin \u03b1v\u03b23.\u3000The Fourth International Symposium on Technetium and Other Radiometals in Chemistry and Medicine, Bressanone, Italy. 2022.09.14-17.<\/li>
          16. The 9th GCB Biomedical Science and Engineering Symposium, Sapporo, 2022.8.20-21, Hirata K: What can and cannot be done with AI in radiology?<\/li>
          17. Tha KK, Katscher U, Hamaguchi H, Li X, Kawasaki T, Yamaguchi S, Yabe I, Hyodoh H. The Role of Electric Properties Tomography in Biochemical Analysis of the Cerebrospinal Fluid and Parameter Optimization for Improved Accuracy. Proc. Intl. Soc. Mag. Reson. Med. 30 (2022) 3648. Joint Annual Meeting ISMRM-ESMRMB, Hybrid (London).<\/li>
          18. Katscher U, Tha KK. Normalization of conductivity maps to support identification of pathologic areas. Proc. Intl. Soc. Mag. Reson. Med. 30 (2022) 3296. Joint Annual Meeting ISMRM-ESMRMB, London.<\/li>
          19. Sakamoto D, Kitagawa M, Hamaguchi H, Yamada K, Sudo H, Tha KK. Potential of Quantitative MRI Indices in Evaluating Lumbar Intervertebral Disc Degeneration. The 4th Asian Society of Magnetic Resonance in Medicine, Hybrid (Taipei).<\/li>
          20. Kitagawa M, Sawamura D, Urushibata Y, Tha KK. Impact of Virtual International Conferences on the brain\u2019s metabolism and cognitive performance. A0104026. The 4th Asian Society of Magnetic Resonance in Medicine, Hybrid (Taipei).<\/li>
          21. Oppong PK, Tha KK. MRI Data Repositories for Glioblastoma Image-Based Research. A0203001. The 4th Asian Society of Magnetic Resonance in Medicine, Hybrid (Taipei).<\/li>
          22. Hamaguchi H, Urushibata Y, Patzke N, Hyodoh H, Ito Y, Tha KK. Correlation between MRI myelin indices and myelin staining in human brain. The 50th anniversary meeting of JSMRM (Nagoya).<\/li>
          23. Kitagawa M, Sawamura D, Urushibata Y, Li X, Hamaguchi H, Yang H, Tha KK. Effect of nighttime wakefulness on the brain's metabolism. The 50th anniversary meeting of JSMRM (Nagoya).<\/li>
          24. Kitagawa M, Sawamura D, Urushibata Y, Hamaguchi H, Tha KK. Effect of nighttime wakefulness on the glymphatic system, the brain's metabolites, and cognition. The 7th annual scientific meeting of the ISMRM Japanese Chapter (Nagoya).<\/li>
          25. Tha KK, Katscher U, Hamaguchi H, Li X, Kawasaki T, Yamaguchi S, Yabe I, Hyodoh H. Biochemical Analysis of the Cerebrospinal Fluid Using Electric Properties Tomography. 2022 Joint Workshop on MR phase, magnetic susceptibility and electrical properties mapping (Lucca).<\/li><\/ol><\/section>","protected":false},"excerpt":{"rendered":"Keynote Speeches\uff1a\u57fa\u8abf\u8b1b\u6f14(\u56fd\u5185)\u300c\u533b\u7642\u306b\u304a\u3051\u308b\u793e\u4f1a\u60c5\u5831\u57fa\u76e4\u3068AI\u300d.\u3000\u4e2d\u8c37 \u7d14\uff0e\u5317\u6d77\u9053\u5927\u5b66\u5927\u5b66\u9662\u533b\u5b66\u7814\u7a76\u9662\u30fb\u533b\u5b66\u9662\u30fb\u533b\u5b66\u90e8\u533b\u5b66\u79d1. \u300c\u65b0\u4efb\u6559\u6388\u7279\u5225\u30bb\u30df\u30ca\u30fc\u300d.\u30002022\u5e7412\u670822\u65e5\u300cICD-11\u3068AI […]","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/c-mng.cwh.hokudai.ac.jp\/gcb.med\/JP\/wp-json\/wp\/v2\/pages\/1423"}],"collection":[{"href":"https:\/\/c-mng.cwh.hokudai.ac.jp\/gcb.med\/JP\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/c-mng.cwh.hokudai.ac.jp\/gcb.med\/JP\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/c-mng.cwh.hokudai.ac.jp\/gcb.med\/JP\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/c-mng.cwh.hokudai.ac.jp\/gcb.med\/JP\/wp-json\/wp\/v2\/comments?post=1423"}],"version-history":[{"count":10,"href":"https:\/\/c-mng.cwh.hokudai.ac.jp\/gcb.med\/JP\/wp-json\/wp\/v2\/pages\/1423\/revisions"}],"predecessor-version":[{"id":1531,"href":"https:\/\/c-mng.cwh.hokudai.ac.jp\/gcb.med\/JP\/wp-json\/wp\/v2\/pages\/1423\/revisions\/1531"}],"wp:attachment":[{"href":"https:\/\/c-mng.cwh.hokudai.ac.jp\/gcb.med\/JP\/wp-json\/wp\/v2\/media?parent=1423"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}